Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rega Biotechnology is a Taiwan-based diagnostics company focused on developing, manufacturing, and commercializing lateral-flow rapid tests and related instrumentation. The company markets assays for plant viruses, finfish viruses, food allergens, mycotoxins, and other preventive testing applications, and also provides antibody production, assay development, OEM/ODM, and contract manufacturing services. Its product portfolio includes lateral-flow test kits, nucleic-acid rapid detection kits, readers, and small-scale printing equipment for assay prototyping and production. Rega appears to operate as a commercial-stage diagnostics supplier rather than a therapeutics developer, with an emphasis on agriculture, food safety, and selected health-related testing applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rega.